These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 17589542)

  • 1. Control points in NKT-cell development.
    Godfrey DI; Berzins SP
    Nat Rev Immunol; 2007 Jul; 7(7):505-18. PubMed ID: 17589542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A role for natural killer T cells and CD1d molecules in counteracting suppression of hematopoiesis in mice induced by infection with murine cytomegalovirus.
    Broxmeyer HE; Dent A; Cooper S; Hangoc G; Wang ZY; Du W; Gervay-Haque J; Sriram V; Renukaradhya GJ; Brutkiewicz RR
    Exp Hematol; 2007 Apr; 35(4 Suppl 1):87-93. PubMed ID: 17379092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular profiling reveals distinct functional attributes of CD1d-restricted natural killer (NK) T cell subsets.
    Rolf J; Berntman E; Stenström M; Smith EM; Månsson R; Stenstad H; Yamagata T; Agace W; Sigvardsson M; Cardell SL
    Mol Immunol; 2008 May; 45(9):2607-20. PubMed ID: 18304639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Innate immunity: NKT cells in the spotlight.
    Van Kaer L; Joyce S
    Curr Biol; 2005 Jun; 15(11):R429-31. PubMed ID: 15936267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NKT cells: T lymphocytes with innate effector functions.
    Van Kaer L
    Curr Opin Immunol; 2007 Jun; 19(3):354-64. PubMed ID: 17428648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invariant NKT and NKT-like lymphocytes: two different T cell subsets that are differentially affected by ageing.
    Peralbo E; Alonso C; Solana R
    Exp Gerontol; 2007 Aug; 42(8):703-8. PubMed ID: 17604928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD1d-restricted glycolipid antigens: presentation principles, recognition logic and functional consequences.
    Florence WC; Bhat RK; Joyce S
    Expert Rev Mol Med; 2008 Jul; 10():e20. PubMed ID: 18601810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycolipids for natural killer T cells.
    Savage PB; Teyton L; Bendelac A
    Chem Soc Rev; 2006 Sep; 35(9):771-9. PubMed ID: 16936925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of NKT cells in the digestive system. III. Role of NKT cells in intestinal immunity.
    Zeissig S; Kaser A; Dougan SK; Nieuwenhuis EE; Blumberg RS
    Am J Physiol Gastrointest Liver Physiol; 2007 Dec; 293(6):G1101-5. PubMed ID: 17717040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. beta-Glycosphingolipids as immune modulators.
    Adar T; Ilan Y
    J Immunotoxicol; 2008 Apr; 5(2):209-20. PubMed ID: 18569392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating V(alpha24+) Vbeta11+ NKT cell numbers are decreased in a wide variety of diseases that are characterized by autoreactive tissue damage.
    van der Vliet HJ; von Blomberg BM; Nishi N; Reijm M; Voskuyl AE; van Bodegraven AA; Polman CH; Rustemeyer T; Lips P; van den Eertwegh AJ; Giaccone G; Scheper RJ; Pinedo HM
    Clin Immunol; 2001 Aug; 100(2):144-8. PubMed ID: 11465942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insufficient ex vivo expansion of Valpha24(+) natural killer T cells in malignant lymphoma patients related to the suppressed expression of CD1d molecules on CD14(+) cells.
    Imataki O; Heike Y; Makiyama H; Iizuka A; Ikarashi Y; Ishida T; Wakasugi H; Takaue Y
    Cytotherapy; 2008; 10(5):497-506. PubMed ID: 18608348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions between B-lymphocytes and type 1 NKT cells in autoimmune diabetes.
    Dufour FD; Silveira PA; Baxter AG
    J Immunotoxicol; 2008 Apr; 5(2):249-57. PubMed ID: 18569396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chewing the fat on natural killer T cell development.
    Godfrey DI; McConville MJ; Pellicci DG
    J Exp Med; 2006 Oct; 203(10):2229-32. PubMed ID: 17000869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The diverse functions of CD1d-restricted NKT cells and their potential for immunotherapy.
    Yu KO; Porcelli SA
    Immunol Lett; 2005 Aug; 100(1):42-55. PubMed ID: 16083968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycolipids as immune modulatory tools.
    Lalazar G; Preston S; Zigmond E; Ben Yáacov A; Ilan Y
    Mini Rev Med Chem; 2006 Nov; 6(11):1249-53. PubMed ID: 17100636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The study of regulatory T cells and NKT cells in Japan: a historical perspective.
    Arase H; Seino K
    Int Immunol; 2009 Oct; 21(10):1101-3. PubMed ID: 19737781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Recognition of CD1d/glycolipid antigen complex by NKT cells and mechanisms in immune regulation].
    Watarai H; Tashiro T; Chiba T; Taniguchi M
    Tanpakushitsu Kakusan Koso; 2008 Sep; 53(12 Suppl):1584-9. PubMed ID: 21089371
    [No Abstract]   [Full Text] [Related]  

  • 19. The fidelity, occasional promiscuity, and versatility of T cell receptor recognition.
    Godfrey DI; Rossjohn J; McCluskey J
    Immunity; 2008 Mar; 28(3):304-14. PubMed ID: 18342005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of injury-induced suppression of T-cell immunity by the CD1d/NKT cell-specific ligand alpha-galactosylceramide.
    Tulley JM; Palmer JL; Gamelli RL; Faunce DE
    Shock; 2008 Feb; 29(2):269-77. PubMed ID: 17693934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.